Neurotrophic Keratitis

被引：84

作者：

Semeraro, F. ^{[1
]}

Forbice, E. ^{[1
]}

Romano, V. ^{[2
]}

Angi, M. ^{[2
]}

Romano, M. R. ^{[2
,3
]}

Filippelli, M. E. ^{[2
]}

Di Iorio, R. ^{[2
]}

Costagliola, C. ^{[2
]}

机构：

[1] Univ Brescia, Dept Ophthalmol, Eye Clin, IT-25100 Brescia, Italy

[2] Univ Molise, Dept Hlth Sci, Eye Clin, Campobasso, Italy

[3] Ist Clin Humanitas, Eye Unit, Rozzano, Italy

来源：

OPHTHALMOLOGICA | 2014年 / 231卷 / 04期

关键词：

Neurotrophic keratitis; Corneal sensitivity; Trigeminal nerve; Corneal vascularization; Stromal ulcers; NERVE GROWTH-FACTOR; PERSISTENT EPITHELIAL DEFECTS; AMNIOTIC MEMBRANE TRANSPLANTATION; AUTOLOGOUS SERUM APPLICATION; SCLERAL CONTACT-LENSES; IN-VITRO TOXICITY; SEVERE DRY EYE; SUBSTANCE-P; PENETRATING KERATOPLASTY; CORNEAL SENSITIVITY;

D O I：

10.1159/000354380

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

Neurotrophic keratitis (NK) is a rare degenerative corneal disease that occurs as a result of partial or total impairment of trigeminal innervations, leading to a reduction (hypoesthesia) in or loss (anaesthesia) of corneal sensitivity. The impairment of sensory innervation causes a reduction in the lacrimation reflex and the vitality, metabolism and mitosis of epithelial cells, with subsequent deficiency in epithelial repair, stromal and intracellular oedema, loss of microvilli, and abnormal development of the basal lamina. Several recent studies have proposed different therapies based on different aetiopathogenetic theories. The aim of the therapy is to treat aetiopathogenesis and, at the same time, promote corneal healing. In this paper, we report the aetiology, diagnosis, management, and medical and surgical treatment of NK, also indicating future treatments based on the most recent studies. (c) 2013 S. Karger AG, Basel

引用

页码：191 / 197

页数：7

共 50 条

[21] Neurotrophic keratitis in a patient with disseminated lymphangiomatosis
Knickelbein, Jared E.
Stefko, Susan T.
Charukamnoetkanok, Puwat
EYE AND BRAIN, 2009, 1 : 1 - 4
[22] On the Horizon: Biologics and Nutrients for Neurotrophic Keratitis
Gumus, Koray
EYE & CONTACT LENS-SCIENCE AND CLINICAL PRACTICE, 2021, 47 (03): : 154 - 156
[23] THE MOLECULAR-BASIS OF NEUROTROPHIC KERATITIS
CAVANAGH, HD
COLLEY, AM
ACTA OPHTHALMOLOGICA, 1989, 67 : 115 - 134
[24] Neurotrophic keratitis secondary to cerebral malformation
Perez Villena, A.
Dorronzoro Ramirez, E.
Gonzalez Garcia, B.
Jimenez Martinez, J.
NEUROLOGIA, 2017, 32 (01): : 62 - 63
[25] Striate melanokeratosis secondary to neurotrophic keratitis
Pereira, CD
Affeldt, JC
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U125 - U125
[26] PROSE Treatment for Pediatric Patients with Neurotrophic Keratitis
Remington, Crystal Dawn
Jacobs, Deborah S.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
[27] Neurotrophic Keratitis: Definition, clinical presentation and diagnosis
Said, A.
Dua, H.
ACTA OPHTHALMOLOGICA, 2017, 95
[28] Treating corneal perforation related to neurotrophic keratitis
Nanavaty, Mayank
ACTA OPHTHALMOLOGICA, 2024, 102
[29] Neurotrophic keratitis induced by cocaine snorting.
Mantelli, Flavio
Sacchetti, Marta
Lambiase, Alessandro
Bonini, Stefano
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
[30] Dry eye and the treatment of neurotrophic keratitis.
Agarwal, MR
Affeldt, JC
Heidar-Hunter, K
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S31 - S31

← 1 2 3 4 5 →